Mika Nishimura

Mika Nishimura has nearly 30 years of experience in medical technology, serving in a variety of operational and executive capacities. Ms. Nishimura is currently an Operational Partner with Gilde Healthcare Partners, a life-science focused venture fund. She also serves as a board member for Accuray, Inc. (NASDAQ: ARAY) and as a board advisor to Tristel, plc, a UK public medical device company. From 2016 to 2020, Ms. Nishimura served as Vice President of Commercialization at nVision Medical Corporation, an early clinical-stage medical device company acquired by Boston Scientific. Previously, she served as Vice President, Commercial Development at Auxogyn, a medical technology company, acquired by Progyny, Inc. Earlier in her career, Ms. Nishimura served as Vice President of International Sales Operations and Marketing at ev3 Inc., where she held P&L responsibilities for the emerging markets. Ms. Nishimura has an MBA from Harvard Graduate School of Business Administration and a B.A. in Economics from Yale University.